U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Documents

Displaying 1 - 20 of 291 results
 
Collapse Filters
 
Expand Filters         +
October 27, 2020

DEA and USPS unveil Drug Free USA Forever stamp

On behalf of the nearly 10,000 men and women of the Drug Enforcement Administration that are serving today across the United States and in nearly 70 countries around the world, I want to welcome the United States Postal Service, and all of you watching via livestream, to DEA Headquarters and this important event to dedicate a new first class postage stamp.

October 20, 2020

DEA Acting Administrator Timothy Shea Remarks at Project Safeguard Press Conference

DEA Acting Administrator Timothy Shea delivers remarks at a press conference in the DEA-New England offices in Boston, Mass.

 

October 6, 2020

DEA Acting Administrator Tim Shea visits Tallahassee, Florida

In 2019 alone, Mexican cartels shipped hundreds of thousands of pounds of methamphetamine in tractor trailers and personal vehicles across our Southwest border and onto our nation’s highways — then headed straight for our cities and towns across America.

September 30, 2020

Remarks by DEA Acting Assistant Administrator Timothy McDermott at the National Healthcare Fraud Takedown Press Conference

Due to the efforts of DEA and our partners, from January 2017 through August 2020, we have seen the number of opioid prescriptions drop nearly 37 percent, a reduction in over 47 percent of opioids dispensed, and most importantly -- an 18 percent drop in prescription overdose deaths over the last two years.

September 22, 2020

DEA Acting Administrator Timothy Shea Delivers Remarks at the Operation DisrupTor Press Conference

DEA Acting Administrator Timothy Shea Delivers Remarks at the Operation DisrupTor Press Conference

Department of Justice, Washington, D.C.

September 22, 2020

September 21, 2020

Counterfeit Controlled Prescription Drug Availability in Pennsylvania and Delaware

The Drug Enforcement Administration (DEA) Philadelphia Field Division (PFD) is advising law enforcement and public health counterparts of the increased availability of counterfeit controlled prescription drugs (CPDs) – commonly sold as legitimate CPDs with most containing fentanyl/ fentanyl-related compounds (FRC) – in Pennsylvania and Delaware.

September 14, 2020

Fentanyl Used in Vape Pens

While the presence of fentanyl powder (lethal in doses as small as two milligrams) poses a public safety threat, the ingestion of fentanyl via vaping poses a threat of unknown consequences to the user and those nearby.

September 10, 2020

Statement by DEA Acting Administrator Timothy Shea - Operation Crystal Shield

Statement by DEA Acting Administrator Timothy Shea - Operation Crystal Shield Press Conference - Phoenix,Arizona September 10, 2020

September 3, 2020

The 2018 Heroin Signature Program

The Drug Enforcement Administration (DEA) Heroin Signature Program (HSP) analyzes hundreds of wholesale-level heroin samples each year to identify the geographic area—Mexico, South America (SA), Southwest Asia (SWA), or Southeast Asia (SEA)—where the samples were manufactured.

September 3, 2020

Prescription Opioid Threat in Pennsylvania, 2020

The PDIP strives to maintain situational awareness of the threat posed by prescription opioids in Pennsylvania, and to share these analyses with stakeholders in federal, state, and municipal governments. In 2013, the PDIP published a Pharmaceutical Threat Assessment for Pennsylvania that found prescription opioid availability and abuse at epidemic levels. In 2016 and 2019, the PDIP published updated assessments detailing prescription opioid availability and abuse trends; this 2020 assessment builds on the previous analyses.

August 11, 2020

The Drug Situation in Delaware 2020

The Drug Enforcement Administration’s (DEA) Philadelphia Field Division (PFD) Intelligence Program conducted an analysis of drug availability and abuse for the State of Delaware. This product highlights significant findings regarding various drug trends since last reported in 2017.

The primary drug threats identified in Delaware are illicit opioids, cocaine, controlled prescription drugs, and methamphetamine. The determination of drug threats in Delaware considers a variety of factors including: availability, threat to public health, community impact, attendant crime, enforcement activity, seizures, drug abuse and treatment statistics, and propensity for abuse.

The PFD Intelligence Program analyzed the following indicators in this assessment: illicit and controlled prescription drug availability; drug prices and purity; and fatal drug-related overdose data.

August 11, 2020

The 2017 Heroin Signature Program Publication

The HSP (Heroin Signature Program) is one essential component of the DEA’s Intelligence Program to identify trends in heroin trafficking and distribution in the United States. The objective of the program is to identify and quantify the chemical components of heroin seized at U.S. ports of entry (POE), all non-POE heroin seizures weighing more than one kilogram, randomly chosen samples, and special requests for analysis. Samples submitted to the HSP undergo in-depth chemical analysis at the DEA Special Testing and Research Laboratory (SFL1). This chemical analysis allows SFL1 to associate the heroin samples with a production process, or “signature,” which is indicative of a particular geographic source area and processing method.

August 10, 2020

Drug-Caused Deaths Investigated by the Washoe County Regional Medical Examiner

Since 2009, Drug Enforcement Administration (DEA) reporting from the Los Angeles Field Division (LAFD) has explored drug-related mortality in the LAFD area of responsibility (AOR), which includes the State of Nevada. In 2019, LAFD personnel reviewed post-mortem toxicology records from the period between 2015 and 2018. These records show that the rate of drug-caused deaths per 100,000 in Washoe County alone increased by more than 130 percent during these four year.

July 8, 2020

Drug Availability in Pennsylvania, 2017-19

DEA's Philadelphia Division conducted a review of laboratory analyzed drug seizures for Pennsylvania. The results of analyzing this data formed the basis for estimating the level of drugs present in Pennsylvania and highlights trends in drug availability. 

June 5, 2020

Vaping and Marijuana Concentrates

DEA's revised and updated drug fact sheet about vaping and marijuana concentrates - what are they, what their origin is, what are the common street names for vaping and marijuana concentrates, what do vapes and various concentrates look like, how they are used/abused, what their effect of their use on the minds and bodies of users including signs of overdose, and their legal status. 

June 5, 2020

Synthetic Opioids - Drug Fact Sheet

DEA's revised and updated drug fact sheet about the class of drugs known as synthetic opioids - what are they, what their origin is, what are common street names for these drugs, what do they look like, how they are abused, what their effect is on the minds and bodies of users including signs of overdose, and their legal status. 

June 5, 2020

Stimulants - Drug Fact Sheet

DEA's revised and updated drug fact sheet about the class of drugs known as stimulants - what are they, what is their origin and history, what are the common street names for these drugs, what do they look like, how they are abused, what their effect is on the minds and bodies of users including signs of overdose, and their legal status. 

June 5, 2020

Steroids - Drug Fact Sheet

DEA's revised and updated drug fact sheet about the class of drugs known as steroids - what they are, what is their origin, what are the common street names for these drugs, what do they look like, how they are abused, what their effect is on the minds and bodies of users including signs of overdose, and their legal status. 

June 5, 2020

Salvia Divinorum - Drug Fact Sheet

DEA's revised and updated drug fact sheet about the drug salvia divinorum - its history, what it is, common street names, what it looks like, how it is abused, what its effect is on the minds and bodies of users including signs of overdose, and its legal status. 

June 5, 2020

Rohypnol - Drug Fact Sheet

DEA's revised and updated drug fact sheet about the sedative Rohypnol - what it is and its history, common street names, what it looks like, how it is abused, what its effect is on the minds and bodies of users including signs of overdose, and its legal status. 

DEA US Badge
United States Drug Enforcement Administration DEA.gov is an official site of the U.S. Department of Justice